AFLAC Incorporated (AFL) : Norges Bank reduced its stake in AFLAC Incorporated by 2.87% during the most recent quarter end. The investment management company now holds a total of 27,149,212 shares of AFLAC Incorporated which is valued at $1,869,766,230 after selling 802,132 shares in AFLAC Incorporated , the firm said in a disclosure report filed with the SEC on May 10, 2016.AFLAC Incorporated makes up approximately 0.94% of Norges Bank’s portfolio.
Other Hedge Funds, Including , Gideon Capital Advisors sold out all of its stake in AFL during the most recent quarter. The investment firm sold 5,402 shares of AFL which is valued $372,036.Salient Trust Co Lta reduced its stake in AFL by selling 4,619 shares or 53.9% in the most recent quarter. The Hedge Fund company now holds 3,951 shares of AFL which is valued at $272,105. AFLAC Incorporated makes up approx 0.03% of Salient Trust Co Lta’s portfolio.Tiaa Cref Investment Management reduced its stake in AFL by selling 290,273 shares or 13.1% in the most recent quarter. The Hedge Fund company now holds 1,925,775 shares of AFL which is valued at $132,589,609. AFLAC Incorporated makes up approx 0.10% of Tiaa Cref Investment Management’s portfolio.Wallington Asset Management reduced its stake in AFL by selling 650 shares or 0.97% in the most recent quarter. The Hedge Fund company now holds 66,276 shares of AFL which is valued at $4,563,103. AFLAC Incorporated makes up approx 1.49% of Wallington Asset Management’s portfolio.Intrust Bank Na reduced its stake in AFL by selling 149 shares or 3.63% in the most recent quarter. The Hedge Fund company now holds 3,954 shares of AFL which is valued at $272,233. AFLAC Incorporated makes up approx 0.10% of Intrust Bank Na’s portfolio.
AFLAC Incorporated opened for trading at $68.56 and hit $69.28 on the upside on Monday, eventually ending the session at $69.02, with a gain of 0.82% or 0.56 points. The heightened volatility saw the trading volume jump to 31,06,709 shares. Company has a market cap of $28,573 M.
On the company’s financial health, AFLAC Incorporated reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.11 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $1.63. The company had revenue of $5451.00 million for the quarter, compared to analysts expectations of $5287.72 million. The company’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.54 EPS.
Many Wall Street Analysts have commented on AFLAC Incorporated. Shares were Downgraded by FBR Capital on May 10, 2016 to ” Mkt Perform” and Lowered the Price Target to $ 68 from a previous price target of $71 .Company shares were Reiterated by RBC Capital Mkts on Apr 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 67 from a previous price target of $64 .Company shares were Reiterated by UBS on Apr 27, 2016 to “Neutral”, Firm has raised the Price Target to $ 67 from a previous price target of $62 .
Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance which is marketed and administered through its subsidiary American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products including cancer plans medical indemnity plans medical/sickness riders care plans living benefit life plans ordinary life insurance plans and annuities. Aflac U.S. sells insurance products including products designed to protect individuals from depletion of assets such as accident cancer critical illness/care hospital intensive care hospital indemnity fixed-benefit dental and vision care plans and loss-of-income products.